Logo, blauer Pfeil Firmenlogo Biomed-Cobcept
Course Program Monday
Deutsche Flagge, Sprache Deutsch 

Details for "Fortbildungsveranstaltung zur Biostoffverordnung (BioStoffV)" only as PDF Download for reading and printing. (only in german language)

Advanced Training Course according to
§ 15 of the German Genetic Engineering Safety Regulations (GenTSV)

Course Director: Reinhard Geßner, MD, PhD
Deputy Director of Institut for Laboratory Medicine,
Pathobiochemistry and Molecular Diagnostics
Universitätsklinikum Giessen-Marburg

Please download printable version here.

Schedule Topics and Contents Lecturer
  8:15 Arrival and registration of participants; distribution of course materials
Venue: Deutsche PhysikalischeGesellschaft e.V., Magnus-Haus Berlin   → City-map
8:45 - 9:30 Welcome and Course Introduction
- Presentation of the course concept
- Risks linked to genetic engineering
- Introduction of regulations in the USA and in Germany
- Hierarchy of European and German regulations
- Position statements by the ZKBS
R. Geßner, MD, PhD
Deputy Director
Institut for Laboratory Medicine,
Pathobiochemistry and Molecular Diagnostics
Universitätsklinikum Giessen-Marburg
9:30 - 10:15 Introduction to the German Genetic Engineering Act (GenTG)
- Definitions used in German genetic engineering regulations
- Central Committee on Biological Safety (ZKBS)
- Biohazard risk reduction principle
- System of biosafety levels 1 to 4
R. Geßner, MD, PhD
Deputy Director
Institut for Laboratory Medicine,
Pathobiochemistry and Molecular Diagnostics
Universitätsklinikum Giessen-Marburg
10:15 - 10:30 Coffee Break
10:30 - 11:15 German Federal Regulations on Genetic Engineering
- Structure, legal definitions and interpretation of German laws
- European regulations of genetic engineering
- Application of the regulations in a genetic engineering facilities
- Regulations that are directly related to the Genetic Engineering Act
W. Pellnitz, Med.Dir. a.D.
Former Head of Abt. I C,
Berlin State Office of Health
and Social Affairs (LAGeSo)
Berlin
11:15 - 12:00 Genetic Engineering Act (GenTG)
- Announcement, registration and licensing of
   genetic engineering facilities and projects
- Controlled release of GMO and placing on the market
- Confidentiality of information provided to the authorities
- Decision process of the permit authority
- Public participation process
- Liabilities, fines and penalties
W. Pellnitz, Med.Dir. a.D.
Former Head of Abt. I C,
Berlin State Office of Health
and Social Affairs (LAGeSo)
Berlin
12:00 - 13:00 Microbial Infections
- Routes of infection with viruses, bacteria and parasites
- Pathogenesis and epidemiology
- Immunological aspects including vaccination
- Preventive measures and therapy<
Prof. H. Zeichhardt, PhD
Institute for Quality Validation
in Viral Disease Diagnostics -
(IQVD), Berlin
or
H.-P. Grunert, PhD
Biotechnological Diagnostics
Corporation (GBD), Berlin
13:00 - 14:15 Lunch Break
14:15 -15:45 Construction, Equipment and Maintenance of Genetic Engineering Facilities
- Requirements according to the German Genetic Engineering Safety Regulations
- Practical approach to fulfill the requirements when
   building and operating a genetic engineering facility
R. Geßner, MD, PhD
Deputy Director
Institut for Laboratory Medicine,
Pathobiochemistry and Molecular Diagnostics
Universitätsklinikum Giessen-Marburg
15:45 - 16:00 Coffee Break
16:00 - 17:00 Sterilization, Disinfection, Inactivation
- Sterilization by physical procedures
- Surface disinfection
- Hand disinfection
R. Geßner, MD, PhD
Deputy Director
Institut for Laboratory Medicine,
Pathobiochemistry and Molecular Diagnostics
Universitätsklinikum Giessen-Marburg
17:00 - 18:00 Genetically Modified Plants
- Risk assessment
- Biosafety classification
- Environmental considerations upon conducting deliberate
   controlled release experiments
- Placing on the market of genetically modified plants
Th. Pickardt, PhD
Institute of Applied Genetics
Free University of Berlin
from 18:00 ... Networking and Refreshments

       ... forward to Tuesday